BRATICA JOSEPH (Principal Financial Officer) sold 12.0% of their position (1.11K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $184.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/14/2020ACC: 0001209191-20-063355
Officer· Principal Financial Officer
Since Aug 2020
-1.11K
Net shares
Net seller
$184.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.11K acquired · 2.23K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.11K
Price / share
$71.45
Trade value
$79.67K
% of position
13.7%
12/11/2020
8.14K→9.26K
Common Stock
Direct
Shares
−1.11K
Price / share
$165.00
Trade value
$183.97K
% of position
12.0%
12/11/2020
9.26K→8.14K
Total
Net shares
+0.00
Net value
-$104.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2020 | M · Option Exercise | +1.11K | $71.45 | $79.67K | 13.7% | 8.14K | 9.26K |
| Common Stock Direct | 12/11/2020 | S · Sale | −1.11K | $165.00 | $183.97K | 12.0% | 9.26K | 8.14K |
| Total | +0.00 | -$104.31K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
1.11K shares
Shares
−1.11K
Strike price
71.45
Held after
12.29K
Exercisable
—
12/11/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock1.11K shares | 12/11/2020 | M · Option Exercise | −1.11K | 71.45 | — | 12.29K |